Literature DB >> 32696713

Patient-Level and Hospital-Level Risk Factors for In-Hospital Mortality in Patients Ventilated for More Than 24 Hours: Results of a Nationwide Cohort Study.

Olaf Schoffer1, Martin Roessler1, Felix Walther1,2, Maria Eberlein-Gonska2, Peter C Scriba3, Michael Albrecht3,4, Ralf Kuhlen3, Jochen Schmitt1.   

Abstract

BACKGROUND: Prolonged ventilation is associated with a high risk of death. This study investigated both patient-level and hospital-level risk factors for in-hospital mortality in patients ventilated for more than 24 hours.
METHODS: The analyses were conducted in the framework of a German national multicenter retrospective cohort study. Patient and hospital characteristics were examined using descriptive statistics. Risk factors of in-hospital mortality were analyzed using multilevel robust Poisson regressions for binary outcomes. Potential effect modifications were examined by stratified analyses.
RESULTS: The sample includes 95 672 cases of patients ventilated >24 hours in 163 hospitals covering the period 2016 to 2017. According to the results of multilevel Poisson regressions, main patient-level risk factors for in-hospital mortality were age (per year relative risk [RR] = 1.021, 95% CI = 1.020-1.023), stroke (RR = 1.459; 95% CI = 1.361-1.563), emergency case admission (RR = 1.273, 95% CI = 1.156-1.403), and transfer from another hospital (RR = 1.169, 95% CI = 1.084-1.261). The individual risk of in-hospital death was positively associated with hospital size (RR of hospitals with 600-799 beds vs <100 beds = 1.412, 95% CI = 1.095-1.820) and negatively related to cumulated ventilation patient time (per 1000 days RR = 0.995, 95% CI = 0.993-0.996). University hospital status was identified as an effect modifier, particularly with regard to the patients' admission reasons. The RR of in-hospital death in patients admitted after transfer from another hospital was higher in university hospitals (RR = 1.456, 95% CI = 1.298-1.634) compared to nonuniversity hospitals (RR = 1.077, 95% CI = 1.019-1.139). Likewise, patients admitted as emergency case had a higher relative risk in university hospitals (RR = 1.619, 95% CI = 1.359-1.929) than in nonuniversity hospitals (RR = 1.141, 95% CI = 1.080-1.205).
CONCLUSION: By providing evidence on multiple patient-level and hospital-level risk factors for in-hospital mortality in patients ventilated for more than 24 hours, this large multicenter study has main implications for quality assessment of clinical care and the adequate specification of risk adjustment models. The revealed effect modifications indicate the relevance of stratified analyses.

Entities:  

Keywords:  cohort study; hospital mortality; multilevel analysis; regression analysis; risk factors; ventilation

Mesh:

Year:  2020        PMID: 32696713     DOI: 10.1177/0885066620942182

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  3 in total

1.  Exploring relationships between in-hospital mortality and hospital case volume using random forest: results of a cohort study based on a nationwide sample of German hospitals, 2016-2018.

Authors:  Martin Roessler; Felix Walther; Maria Eberlein-Gonska; Peter C Scriba; Ralf Kuhlen; Jochen Schmitt; Olaf Schoffer
Journal:  BMC Health Serv Res       Date:  2022-01-02       Impact factor: 2.655

2.  Relationships between multiple patient safety outcomes and healthcare and hospital-related risk factors in colorectal resection cases: cross-sectional evidence from a nationwide sample of 232 German hospitals.

Authors:  Felix Walther; Jochen Schmitt; Maria Eberlein-Gonska; Ralf Kuhlen; Peter Scriba; Olaf Schoffer; Martin Roessler
Journal:  BMJ Open       Date:  2022-07-25       Impact factor: 3.006

3.  Prediction of inpatient pressure ulcers based on routine healthcare data using machine learning methodology.

Authors:  Felix Walther; Luise Heinrich; Jochen Schmitt; Maria Eberlein-Gonska; Martin Roessler
Journal:  Sci Rep       Date:  2022-03-23       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.